New-onset psychosis following COVID-19 infection in a patient with no psychiatric history: A longitudinal case report
- PMID: 36457730
- PMCID: PMC9287465
- DOI: 10.1016/j.psycr.2022.100035
New-onset psychosis following COVID-19 infection in a patient with no psychiatric history: A longitudinal case report
Abstract
Background: Viral infection, including COVID-19, has been implicated as a potential cause of various neurobehavioral issues. An increasing number of case reports suggest that current or recent COVID-19 infection may cause new onset of psychotic symptoms in some individuals, potentially related to viral inflammation or infection of the nervous system.
Case presentation: A 26-year-old woman with no psychiatric history presented with severe psychotic symptoms days after recovery from a mild COVID-19 infection. No other etiologies for psychosis were identified via diagnostic testing, review of medical history, or interviews with family. Her symptoms persisted for approximately two months, requiring three inpatient admissions, various medication trials, and ongoing outpatient follow-up. With continued use of quetiapine and lithium, she returned to living independently and working full-time, and discontinued all medication approximately nine months after symptom onset.
Conclusion: The psychiatric and cognitive effects of COVID-19 infection are not yet fully understood. Given the widespread and ongoing nature of this pandemic, this remains an important focus of further investigation, especially within the context of potential long-term complications.
Keywords: Acute psychosis; Lithium; Outcome metrics; SARS-CoV-2; Treatment-refractory psychosis; Viral inflammation.
© 2022 Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Acute mania following COVID-19 in a woman with no past psychiatric history case report.BMC Psychiatry. 2022 Jul 20;22(1):486. doi: 10.1186/s12888-022-04110-y. BMC Psychiatry. 2022. PMID: 35858846 Free PMC article.
-
Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.Turk Psikiyatri Derg. 2022 Summer;33(2):143-145. doi: 10.5080/u25957. Turk Psikiyatri Derg. 2022. PMID: 35730515 English, Turkish.
-
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.
-
Psychotic disorders amid the COVID-19 pandemic: a consideration of risks and impacts.Curr Opin Psychiatry. 2022 May 1;35(3):140-145. doi: 10.1097/YCO.0000000000000784. Epub 2022 Feb 7. Curr Opin Psychiatry. 2022. PMID: 35125397 Review.
-
First-episode psychotic disorders in the wake of the COVID-19 pandemic: a descriptive review of casereports.Acta Neuropsychiatr. 2022 Dec;34(6):289-310. doi: 10.1017/neu.2022.11. Epub 2022 Mar 31. Acta Neuropsychiatr. 2022. PMID: 35357298 Review.
Cited by
-
First-episode psychiatric disorder risk from SARS-CoV-2 infection: A clinical analysis with Chinese psychiatric inpatients.J Biomed Res. 2024 May 29;39(1):50-60. doi: 10.7555/JBR.38.20240005. J Biomed Res. 2024. PMID: 38807424 Free PMC article.
-
Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling.Neuropsychopharmacol Rep. 2025 Mar;45(1):e12520. doi: 10.1002/npr2.12520. Neuropsychopharmacol Rep. 2025. PMID: 39754403 Free PMC article. Review.
References
-
- Ferrando S.J., Klepacz L., Lynch S., Tavakkoli M., Dornbush R., Baharani R., Smolin Y., Bartell A. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551–555. doi: 10.1016/j.psym.2020.05.012. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous